(1S,2R)-1-((tert-Butoxycarbonyl)amino)-2-vinylcyclopropanecarboxylic acid, 97%, 1g

(S)-1-Benzyl 3-methyl pyrrolidine-1,3-dicarboxylate, 95.0%, 1g

2,2-DIMETHYLTETRAHYDRO-2H-PYRAN-4-AMINE HCL, 95.0%, 500mg

4-morpholin-4-ylbutan-1-ol, 95.0%, 100mg

4-tert-Butylbenzaldehyde>95.0%(GC)500g

[1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene](1,3-diphenyl-1,3-propanedionato)copper(I)>98.0%(T)1g

2,5-Difluoropyridine>98.0%(GC)5g

6-Methylimidazo[2,1-b][1,3]thiazole-5-carboxylic acid, 95.0%, 25g

(R)-3-(5-(2-aminopropyl)-7-cyanoindolin-1-yl)propyl benzoate (2R,3R)-2,3-dihydroxysuccinate, 96%, 5g

Nipecotamide>98.0%(T)5g

1-Phenylpropan-2-ol, 99.0%, 100g

Cytidine 5'-Monophosphate>98.0%(HPLC)5g

Bis(2-ethylhexanoato)hydroxyaluminum>98.0%(T)25g